Gts Securities »

Bluebird Bio shares owned by Gts Securities

Quarter-by-quarter ownership of Bluebird Bio (BLUE) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Bluebird Bio

Tip: Access up to 7 years of quarterly data

All positions including Bluebird Bio held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bluebird Bio by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $653k 473k 1.38
2023-09-30 $500k 164k 3.04
2023-06-30 $137k 42k 3.29

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding Bluebird Bio

Vanguard Group
Alyeska Investment Group
Norges Bank Investment Management
Millennium Management
Palo Alto Investors
Dimensional Fund Advisors
Two Sigma Investments
Bleichroeder
Citadel Advisors
Hudson Bay Capital Management
Partner Fund Management
Jpmorgan Chase & Co
Frazier Life Sciences Management
Tang Capital Management
Bank of America Corporation

View all funds holding Bluebird Bio